Instrument

Infections after surgery are more likely due to bacteria already on your skin than from microbes in the hospital − new research

Retrieved on: 
Wednesday, April 10, 2024

Genetic data from the bacteria causing these infections – think CSI for E. coli – tells another story: Most health care-associated infections are caused by previously harmless bacteria that patients already had on their bodies before they even entered the hospital.

Key Points: 
  • Genetic data from the bacteria causing these infections – think CSI for E. coli – tells another story: Most health care-associated infections are caused by previously harmless bacteria that patients already had on their bodies before they even entered the hospital.
  • We show that many surgical site infections after spinal surgery are caused by microbes that are already on the patient’s skin.

Surgical infections are a persistent problem

  • Among the different types of heath care-associated infections, surgical site infections stand out as particularly problematic.
  • A 2013 study found that surgical site infections contribute the most to the annual costs of hospital-acquired infections, totaling over 33% of the US$9.8 billion spent annually.
  • Still, surgical site infections occur following about 1 in 30 procedures, typically with no explanation.
  • While rates of many other medical complications have shown steady improvement over time, data from the Agency for Healthcare Research and Quality and the Centers for Disease Control and Prevention show that the problem of surgical site infection is not getting better.

BYOB (Bring your own bacteria)

  • Prior studies on surgical site infection have been limited to a single species of bacteria and used older genetic analysis methods.
  • But new technologies have opened the door to studying all types of bacteria and testing their antibiotic resistance genes simultaneously.
  • Over a one-year period, we sampled the bacteria living in the nose, skin and stool of over 200 patients before surgery.
  • In fact, 86% of the bacteria causing infections after spine surgery were genetically matched to bacteria a patient carried before surgery.
  • That number is remarkably close to estimates from earlier studies using older genetic techniques focused on Staphylococcus aureus.
  • They likely acquired these antibiotic-resistant microbes through prior antibiotic exposure, consumer products or routine community contact.

Preventing surgical infections

  • At face value, our results may seem intuitive – surgical wound infections come from bacteria that hang out around that part of the body.
  • If the most likely source of surgical infection – the patient’s microbiome – is known in advance, this presents medical teams with an opportunity to protect against it prior to a scheduled procedure.
  • The fact that most infections don’t actually start with sources in the hospital is probably a testament to the efficacy of these protocols.


Dustin Long receives funding from the National Institutes of Health. Dr Bryson-Cahn receives funding from the Gordon and Berry Moore Foundation and is the co-medical director for Alaska Airlines.

Precision Neuroscience Names Verily Co-Founder Brian Otis as Chief Technology Officer

Retrieved on: 
Monday, April 8, 2024

NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation (Precision) today announced that Dr. Brian Otis has joined the company as Chief Technology Officer.

Key Points: 
  • NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation (Precision) today announced that Dr. Brian Otis has joined the company as Chief Technology Officer.
  • He was one of the co-founders of Verily, Alphabet Inc.’s healthcare and life sciences company, where he served as Chief Technical Officer and Fellow from 2015 through 2022.
  • He oversaw a large, multidisciplinary team in the end-to-end development of new medical technology, from discovery to manufacturing.
  • Under Otis’ technical leadership, Verily entered a number of significant collaborations with leading healthcare and pharmaceutical partners.

Fujifilm to Debut New Products for Broadcast, Cinema, and Digital Content Creators at NAB 2024

Retrieved on: 
Thursday, April 4, 2024

VALHALLA, N.Y., April 04, 2024 (GLOBE NEWSWIRE) -- FUJIFILM North America Corporation’s Electronic Imaging and Optical Devices Divisions will debut a variety of new gear and technology at the 2024 National Association of Broadcasters Show (NAB 2024) from April 14 – 17, 2024 in Las Vegas.

Key Points: 
  • VALHALLA, N.Y., April 04, 2024 (GLOBE NEWSWIRE) -- FUJIFILM North America Corporation’s Electronic Imaging and Optical Devices Divisions will debut a variety of new gear and technology at the 2024 National Association of Broadcasters Show (NAB 2024) from April 14 – 17, 2024 in Las Vegas.
  • Duvo™ 25-1000mm was awarded Best Overall Product in the “CREATE” Category of the 2023 NAB Show “Product of the Year” Awards.
  • “The continual excitement around our products is constantly generating conversations and creating new avenues for customers to explore.
  • For more information about Fujifilm's presence at NAB 2024, click here .

ICIC and SRI Release Landmark Report on Enhancing Economic Opportunities in Distressed Communities Through Regional Connectivity

Retrieved on: 
Wednesday, April 3, 2024

Boston, MA, April 03, 2024 (GLOBE NEWSWIRE) -- The Initiative for a Competitive Inner City (ICIC) and SRI today unveiled a groundbreaking report titled " Regional Economic Connectivity: A Strategy to Build Opportunity in Distressed Communities ."

Key Points: 
  • Boston, MA, April 03, 2024 (GLOBE NEWSWIRE) -- The Initiative for a Competitive Inner City (ICIC) and SRI today unveiled a groundbreaking report titled " Regional Economic Connectivity: A Strategy to Build Opportunity in Distressed Communities ."
  • The report aims to bridge the economic divide by fostering connections between distressed communities and the more prosperous parts of their metropolitan areas.
  • "Regional Economic Connectivity" not only identifies the mechanics of economic integration but also provides actionable insights for economic development professionals, policymakers, community leaders, and private and public sector partners.
  • “Through this report, ICIC and SRI offer a novel approach to economic development that prioritizes both growth and equity,” said Howard Wial, Senior Vice President and Director of Research at ICIC.

Thermo Fisher Scientific Innovations at Analytica 2024 Optimize Workflows and Enable Precise Analysis Across Life Sciences, Applied and Industrial Markets

Retrieved on: 
Tuesday, April 9, 2024

Analytica 2024 - Thermo Fisher Scientific, Inc. is debuting its recently launched innovative products, hosting educational presentations and showcasing live lab demos for customers working in laboratory technology, analysis, biotechnology, and environmental quality during the 2024 Analytica Conference.

Key Points: 
  • Analytica 2024 - Thermo Fisher Scientific, Inc. is debuting its recently launched innovative products, hosting educational presentations and showcasing live lab demos for customers working in laboratory technology, analysis, biotechnology, and environmental quality during the 2024 Analytica Conference.
  • “Advancements in data analytics and optimized laboratory workflows that enable fast, precise analysis are key to propelling the field of analytical science forward,” said Dan Shine, senior vice president and president, Analytical Instruments, Thermo Fisher.
  • Real-time monitoring with process analytical technology - The Thermo Scientific™ MarqMetrix™ All-In-One Process Raman Analyzer enables real-time, accurate spectral results for in-line, at-line, or on-line process monitoring.
  • For more information regarding Thermo Fisher products and services exhibited at Analytica 2024, please visit the website or booth 101 in hall B1.

T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates

Retrieved on: 
Wednesday, March 20, 2024

LEXINGTON, Mass., March 20, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced plans for the T2Lyme Panel commercial launch and provided recent business updates.

Key Points: 
  • LEXINGTON, Mass., March 20, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced plans for the T2Lyme Panel commercial launch and provided recent business updates.
  • The Company is currently in discussions with potential LDT partners and plans to provide early Lyme disease results to U.S. reference laboratories nationwide.
  • Engaged Dr. Robin Robinson as a strategic advisor to aid in commercialization of the T2Biothreat Panel.
  • A live and recorded webcast of the call will be available on the “Investors” section of the Company’s website at www.t2biosystems.com .

Global Medical Adhesives & Sealants Market Report 2024 - Wide Array of Solutions and Application Areas Offered by Soft-Skin Adhesives Facilitating Market Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, April 1, 2024

The "Global Medical Adhesives & Sealants Market - Resin Types, Applications and End-use Sectors" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Medical Adhesives & Sealants Market - Resin Types, Applications and End-use Sectors" report has been added to ResearchAndMarkets.com's offering.
  • The growth in demand for soft-skin adhesives has been made possible by the wide variety of their applications in the medical, pharmaceutical and personal care areas.
  • Soft-skin adhesives find application in a range of medical areas, which comprise skin therapies, wound dressing and wearable medical devices, providing further impetus to demand for them.
  • The range of applications for adhesives and sealants the medical sector includes the areas of dentistry & cosmetics, internal & external surgery and medical devices & equipment.

Liquid Instruments brings its Moku test platform to Apple Vision Pro, launching industry-first capabilities for optics research

Retrieved on: 
Wednesday, March 27, 2024

Liquid Instruments , a leading innovator of reconfigurable test instrumentation, today announced that its Moku platform is available for Apple Vision Pro, launching the first interactive 3D test system for optics researchers.

Key Points: 
  • Liquid Instruments , a leading innovator of reconfigurable test instrumentation, today announced that its Moku platform is available for Apple Vision Pro, launching the first interactive 3D test system for optics researchers.
  • View the full release here: https://www.businesswire.com/news/home/20240327538790/en/
    Liquid Instruments announced that its Moku platform is available for Apple Vision Pro, launching the first interactive 3D test system for optics researchers.
  • “Moku for visionOS is the ultimate setup for optics labs,” said Daniel Shaddock, co-founder and CEO of Liquid Instruments.
  • Liquid Instruments aims to empower users to increase efficiency with a reconfigurable suite of versatile, easy-to-use test instruments.

China Dental Market Analysis, Size and Forecasts Report 2023-2030 Featuring Sirona Dental Systems Foshan, Danaher, 3M, Straumann, Zimmer Biomet, Phillips, and Colgate Palmolive - ResearchAndMarkets.com

Retrieved on: 
Friday, March 22, 2024

The "China Dental Market, Size, Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "China Dental Market, Size, Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has been added to ResearchAndMarkets.com's offering.
  • The market has a variety of merchandise like toothpaste, toothbrushes, mouthwashes, dental floss, and other oral hygiene products.
  • Radiology equipment is awaited to grow in the China dental market due to its critical position in analysis and remedy planning.
  • Moreover, technological upgrades and government tasks selling healthcare infrastructure improvement propel the adoption of radiology equipment inside the China dental market.

Notice of Commencement of Operation of Dexerials Photonics Solutions Corporation as Integrated Company Leading Growth in the Photonics Domain

Retrieved on: 
Friday, March 22, 2024

In so doing, the Group will help build a sustainable society, while aiming to achieve continuous growth and higher corporate value.

Key Points: 
  • In so doing, the Group will help build a sustainable society, while aiming to achieve continuous growth and higher corporate value.
  • DXPS will develop and manufacture** microdevices and optical semiconductor device products that have been operated by DXPC and Kyoto Semiconductor.
  • It is hence anticipated that optical semiconductors and the photonics solutions that support them will also have greater roles to play.
  • DXPS will lead the Dexerials Group’s business growth in the photonics domain.